New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Updated September 17th, 2020

New Guidelines On the Use of PARP Inhibitors Help Doctors & Women With Ovarian Cancer Make Smarter Decisions

Guidelines recommend PARP inhibitors for a wider group of women; this is based on recent studies that found these drugs improve survival rates.

NOW
PLAYING
Remembering 'Top Chef's' Fatima Ali, Who Passed 2 Years Ago From Cancer: Has There Been Any Progress On Ewing Sarcoma Since?
NOW
PLAYING
Genetic Testing: What is it and Why is it Important?
NOW
PLAYING
Iowa Woman Found Stage 2 Breast Cancer After Getting COVID-19 Shot: 'As Much as COVID Sucked, It Saved Me'
NOW
PLAYING
Christiane Amanpour Reveals Ovarian Cancer Diagnosis
NOW
PLAYING
Major Advance: PARP Inhibitors Extend Life For Women With High Risk Breast Cancer & BRCA Mutations
NOW
PLAYING
FDA Approves First Targeted Therapy For Lung Cancer Patients With the KRAS Gene Mutation
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.